StockData
Cingulate Inc. logo

Cingulate Inc. (CING) stock

CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.72+0.97 (+25.87%)

Close on Nov 17, 2026Market cap $68.64MP/E –Yield –

Cingulate gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Cingulate

Cingulate has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cingulate figures

See a number that looks wrong?